These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1705641)

  • 1. [Which nasal spray is preferred by patients?].
    Månsson I; Fredriksson H
    Lakartidningen; 1991 Feb; 88(6):406. PubMed ID: 1705641
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
    Jessen M; Ivarsson A; Malm L
    Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymetazoline nasal spray.
    Graf P
    Laryngoscope; 1998 Aug; 108(8 Pt 1):1255. PubMed ID: 9707257
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative preference study between xylometazoline nasal dose spray (Otrivin) and oxymetazoline single-dose pipettes (Nezeril).
    Ekedahl C; Geterud A; Petruson B; Aust R; Odkvist L
    Rhinology; 1983 Sep; 21(3):287-8. PubMed ID: 6195722
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a new oxymetazoline preparation in the treatment of nasal congestion. A multicentre trial.
    Practitioner; 1975 May; 214(1283):685-688. PubMed ID: 49890
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary syndrome after nasal spray of oxymetazoline.
    Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
    Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
    [No Abstract]   [Full Text] [Related]  

  • 9. A topical nasal decongestant for children.
    Neffson AH
    Eye Ear Nose Throat Mon; 1968 Mar; 47(3):121-3. PubMed ID: 4171734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of oxymetazoline in nasal endoscopic sinus surgery].
    Zhen H; Gao Q; Cui Y; Hua X; Li H; Feng J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):281-2. PubMed ID: 12916356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of the effect of oxymetazoline on the duration of rhinitis].
    Reinecke S; Tschaikin M
    MMW Fortschr Med; 2005 Oct; 147(41):46. PubMed ID: 16270513
    [No Abstract]   [Full Text] [Related]  

  • 13. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
    Druce HM; Ramsey DL; Karnati S; Carr AN
    Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging.
    Pritchard S; Glover M; Guthrie G; Brum J; Ramsey D; Kappler G; Thomas P; Stuart S; Hull D; Gowland P
    Pulm Pharmacol Ther; 2014 Feb; 27(1):121-6. PubMed ID: 23988443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison between xylometazoline in a dosage spray and oxymetazoline in one dose pipettes].
    Petruson B; Ekedahl C; Geterud A; Aust R; Odkvist L
    Lakartidningen; 1983 May; 80(18):1908-10. PubMed ID: 6350765
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of topical nasal decongestants.
    Connell JT
    Ann Allergy; 1969 Nov; 27(11):541-6. PubMed ID: 4195892
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiofrequency for inferior turbinate hypertrophy: could its long-term effect be predicted with a preoperative topical vasoconstrictor drop test?
    Yilmaz M; Kemaloğlu YK; Baysal E; Tutar H
    Am J Rhinol; 2006; 20(1):32-5. PubMed ID: 16539291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.